The Production of Antibodies

The Production of Antibodies
Author :
Publisher :
Total Pages : 142
Release :
ISBN-10 : OCLC:491892544
ISBN-13 :
Rating : 4/5 ( Downloads)
DOWNLOAD EBOOK
Book Synopsis The Production of Antibodies by : Frank Macfarlane Burnet

Download or read book The Production of Antibodies written by Frank Macfarlane Burnet and published by . This book was released on 1949 with total page 142 pages. Available in PDF, EPUB and Kindle. Book excerpt:


The Production of Antibodies Related Books

The Production of Antibodies
Language: en
Pages: 142

The Production of Antibodies

Authors: Frank Macfarlane Burnet
Categories:
Type: BOOK - Published: 1949 - Publisher:

DOWNLOAD EBOOK

Janeway's Immunobiology
Language: en
Pages:

Janeway's Immunobiology

Authors: Kenneth Murphy
Categories: Medical
Type: BOOK - Published: 2010-06-22 - Publisher: Garland Science

DOWNLOAD EBOOK

The Janeway's Immunobiology CD-ROM, Immunobiology Interactive, is included with each book, and can be purchased separately. It contains animations and videos wi
Monoclonal Antibody Production
Language: en
Pages: 74

Monoclonal Antibody Production

Authors: National Research Council
Categories: Medical
Type: BOOK - Published: 1999-05-06 - Publisher: National Academies Press

DOWNLOAD EBOOK

The American Anti-Vivisection Society (AAVS) petitioned the National Institutes of Health (NIH) on April 23, 1997, to prohibit the use of animals in the product
Monoclonal Antibodies
Language: en
Pages: 344

Monoclonal Antibodies

Authors: James W. Goding
Categories: Medical
Type: BOOK - Published: 1986 - Publisher:

DOWNLOAD EBOOK

This book represents the distillation and critical evaluation of many hundreds of publications relating to the production and use of antibodies. Therefore it is
Antibody Expression and Production
Language: en
Pages: 349

Antibody Expression and Production

Authors: Mohamed Al-Rubeai
Categories: Medical
Type: BOOK - Published: 2011-05-16 - Publisher: Springer Science & Business Media

DOWNLOAD EBOOK

Engineered antibodies currently represent over 30% of biopharmaceuticals in clinical trials and their total worldwide sales continue to increase significantly.